142 related articles for article (PubMed ID: 38072737)
1. Preoperative C-reactive protein to albumin ratio as a novel prognostic biomarker for the oncological outcomes of radical nephroureterectomy.
Gwak CH; Suh J; Lim B; Song C; You D; Jeong IG; Hong JH; Hong B; Ahn H
Urol Oncol; 2024 Feb; 42(2):30.e17-30.e23. PubMed ID: 38072737
[TBL] [Abstract][Full Text] [Related]
2. The Prognostic Value of Preoperative Naples Prognostic Score in Upper Tract Urothelial Carcinoma Patients after Radical Nephroureterectomy.
Ye J; Chen Z; Pan Y; Liao X; Wang X; Zhang C; Wang Q; Han P; Wei Q; Bao Y
Nutr Cancer; 2024; 76(1):80-88. PubMed ID: 37941300
[TBL] [Abstract][Full Text] [Related]
3. Upper Urinary Tract Urothelial Cancer After Radical Cystectomy for Bladder Cancer: Survival Outcomes After Radical Nephroureterectomy.
Ślusarczyk A; Zapała P; Piecha T; Zapała Ł; Borkowski T; Radziszewski P
Ann Surg Oncol; 2024 Mar; 31(3):2144-2153. PubMed ID: 38085392
[TBL] [Abstract][Full Text] [Related]
4. Adjuvant chemotherapy after radical nephroureterectomy improves the survival outcome of high-risk upper tract urothelial carcinoma patients with cardiovascular comorbidity.
Luo Y; Feng B; Wei D; Han Y; Li M; Zhao J; Lin Y; Hou Z; Jiang Y
Sci Rep; 2020 Oct; 10(1):17674. PubMed ID: 33077839
[TBL] [Abstract][Full Text] [Related]
5. Prognostic Impact of Preoperative Albumin-Globulin Ratio on Oncologic Outcomes in Upper Tract Urothelial Carcinoma Treated With Radical Nephroureterectomy.
Xu H; Tan P; Ai J; Huang Y; Lin T; Yang L; Wei Q
Clin Genitourin Cancer; 2018 Oct; 16(5):e1059-e1068. PubMed ID: 29980449
[TBL] [Abstract][Full Text] [Related]
6. Ten-year survival outcomes after radical nephroureterectomy with a risk-stratified approach using prior diagnostic ureteroscopy: a single-institution observational retrospective cohort study.
Veeratterapillay R; Geraghty R; Pandian R; Roy C; Stenhouse G; Bird C; Soomro N; Paez E; Rogers A; Johnson M; Page T; Rix D; Thomas D; Rai BP
BJU Int; 2022 Jun; 129(6):744-751. PubMed ID: 34726325
[TBL] [Abstract][Full Text] [Related]
7. What is the Role of the Preoperative Blood-Based Inflammation Biomarkers in the Prognosis of Upper Tract Urothelial Carcinoma With Radical Nephroureterectomy? A Single-Centre Retrospective Study.
Luo Z; Jiao B; Huang T; Zhao H; Zhang G
Technol Cancer Res Treat; 2022; 21():15330338221095667. PubMed ID: 35585719
[No Abstract] [Full Text] [Related]
8. Preoperative positive voided urine cytology predicts poor clinical outcomes in patients with upper tract urothelial carcinoma undergoing nephroureterectomy.
Liu W; Wang Z; Liu S; Yao Y; Liu Y; Zhang G
BMC Cancer; 2020 Nov; 20(1):1113. PubMed ID: 33198698
[TBL] [Abstract][Full Text] [Related]
9. Influence of preoperative body mass index on prognosis for patients with upper urinary tract urothelial carcinoma treated with radical nephroureterectomy.
Chen JC; Huang TH; Wei TC; Huang IS; Fan YH; Lin CC; Lin TP; Chung HJ; Lu SH; Kuo JY; Wu HHH; Chang YH; Lin ATL; Huang WJ; Huang EY
World J Urol; 2023 Dec; 41(12):3575-3583. PubMed ID: 37924334
[TBL] [Abstract][Full Text] [Related]
10. Risk factors and oncological outcome for intravesical recurrence in organ-confined upper urinary tract urothelial carcinoma patients after radical nephroureterectomy: A propensity score-matched case control study.
Jiang Y; Yao Z; Zhu X; Wu B; Bai S
Int J Surg; 2020 Apr; 76():28-34. PubMed ID: 32081714
[TBL] [Abstract][Full Text] [Related]
11. Histological variants and lymphovascular invasion in upper tract urothelial carcinoma can stratify prognosis after radical nephroureterectomy.
Takemoto K; Hayashi T; Hsi RS; Kobatake K; Sekino Y; Kitano H; Ikeda K; Goto K; Hieda K; Sentani K; Kajiwara M; Nishizaka T; Teishima J; Oue N; Hinata N
Urol Oncol; 2022 Dec; 40(12):539.e9-539.e16. PubMed ID: 36244916
[TBL] [Abstract][Full Text] [Related]
12. Serum α-hydroxybutyrate dehydrogenase as a biomarker for predicting survival outcomes in patients with UTUC after radical nephroureterectomy.
Ye J; Zheng L; Chen Z; Wang Q; Liao X; Wang X; Wei Q; Bao Y
BMC Urol; 2024 Mar; 24(1):62. PubMed ID: 38509518
[TBL] [Abstract][Full Text] [Related]
13. Presence of secondary bladder cancer following radical nephroureterectomy for upper tract urothelial carcinoma: characteristics, risk factors, and predictive value.
Lai S; Wu P; Liu S; Seery S; Liu J; He L; Liu M; Zhang Y; Wang JY; Xu T
BMC Urol; 2022 Dec; 22(1):211. PubMed ID: 36566200
[TBL] [Abstract][Full Text] [Related]
14. Effects of Variant Histology on the Oncologic Outcomes of Patients With Upper Urinary Tract Carcinoma After Radical Nephroureterectomy: A Propensity Score-Matched Analysis.
Chung HS; Hwang EC; Kim MS; Yu SH; Jung SI; Kang TW; Choi C; Choi SH; Kwon TG; Noh JH; Kim MK; Cho WJ; Kang SG; Kang SH; Cheon J; Seo IY; Chung H; Kim HS; Lee CH; Ku JY; Ha HK; Kim BH; Jeong CW; Ku JH; Kwak C; Kwon D
Clin Genitourin Cancer; 2019 Jun; 17(3):e394-e407. PubMed ID: 30782419
[TBL] [Abstract][Full Text] [Related]
15. Preoperative Monocyte-to-lymphocyte Ratio Predicts for Intravesical Recurrence in Patients With Urothelial Carcinoma of the Upper Urinary Tract After Radical Nephroureterectomy Without a History of Bladder Cancer.
Liu J; Wu P; Lai S; Song X; Fu C; Wang X; Liu S; Hou H; Liu M; Wang J
Clin Genitourin Cancer; 2021 Jun; 19(3):e156-e165. PubMed ID: 33121908
[TBL] [Abstract][Full Text] [Related]
16. Prognostic value of preoperative lymphocyte-related systemic inflammatory biomarkers in upper tract urothelial carcinoma patients treated with radical nephroureterectomy: a systematic review and meta-analysis.
Shao Y; Li W; Wang D; Wu B
World J Surg Oncol; 2020 Oct; 18(1):273. PubMed ID: 33097052
[TBL] [Abstract][Full Text] [Related]
17. Effects of different combinations of radical nephroureterectomy and bladder cuff excision procedures for upper tract urothelial carcinoma on bladder recurrence.
Huang EY; Tai MC; Chung HJ; Chang YH; Huang WJ
Int Braz J Urol; 2023; 49(4):469-478. PubMed ID: 37267612
[TBL] [Abstract][Full Text] [Related]
18. Noninferior oncological outcomes in adults aged 80 years or older compared with younger patients who underwent radical nephroureterectomy for upper tract urothelial carcinoma.
Yamada Y; Ikeda M; Hirayama T; Murakami Y; Koguchi D; Matsuda D; Okuno N; Taoka Y; Utsunomiya T; Irie A; Matsumoto K; Iwamura M
Asia Pac J Clin Oncol; 2023 Jun; 19(3):305-311. PubMed ID: 35909301
[TBL] [Abstract][Full Text] [Related]
19. Impact of a novel immune and nutritional score on prognosis in patients with upper urinary tract urothelial carcinoma following radical nephroureterectomy.
Liu J; Lai S; Wu P; Wang J; Wang J; Wang J; Zhang Y
J Cancer Res Clin Oncol; 2023 Sep; 149(12):10893-10909. PubMed ID: 37318591
[TBL] [Abstract][Full Text] [Related]
20. Variant histology is associated with more non-urothelial tract recurrence but less intravesical recurrence for upper tract urothelial carcinoma after radical nephroureterectomy.
Yu TY; Wang HJ; Sung MT; Chuang YC; Chen YT; Cheng YT; Kang CH; Liu HY; Chang YL; Luo HL
Int J Urol; 2024 Apr; 31(4):410-418. PubMed ID: 38169055
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
